Sveriges mest populära poddar

PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain

1 tim 19 min•26 augusti 2022

Om avsnittet

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.

www.psychedelicstoday.com

Fler avsnitt

PT 661 - Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health

7 okt.1 tim 16 min

PT 660 - Josh Lipson & Roman Palitsky: Psychedelic Harms and the Post-Psychedelic Challenges Study

12 aug.1 tim 13 min

PT 659 - Megan Bowers & Mikayla Hellwich

5 aug.1 tim 21 min

PT 658 - Mareesa Stertz – Sphinx Gate Beyond Burning Man: Psychedelic Healing Without Psychedelics

31 juli1 tim 15 min

PT 657 - Rachel Turetzky PhD & Douglas S. Wingate DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy

23 juli1 tim 19 min

PT 656 - Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

11 maj1 tim 44 min

PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium

8 maj54 min

PT 654 - Erica Rex - Seeing What Is There

23 apr.1 tim 21 min

PT 653 - Dr. Michael Alpert and Peter Alberding - ALS, Existential Distress, and Ketamine Therapy

16 apr.1 tim 19 min

PT 652 - Esme Dark - Psychedelics, Somatics and the Shadow

25 mars1 tim 14 min

Psychedelics Today med Psychedelics Today finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.